NCT03215810 2023-07-24
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
M.D. Anderson Cancer Center
Ontario Clinical Oncology Group (OCOG)
Massachusetts General Hospital